Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-18-003376

Options or other derivatives

  • Chief Financial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RAY DEBANJAN · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-24 Grant or award : show line 1 in the form Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc1.xml…